|
|
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Krupanidhi Group of Institutions
0 Patents (Medical) associated with Krupanidhi Group of Institutions
01 Jun 2018·Vision: The Journal of Business Perspective
Case Analysis I: Challenges MNCs Face in Emerging Markets: The Nestlé Experience
100 Deals associated with Krupanidhi Group of Institutions
100 Translational Medicine associated with Krupanidhi Group of Institutions